Table 6.

Conventional ADHD medication type and dose used by the conventional medication group (TAU) in the past 2 weeks assessed at the 2- (2 W) and 4-week (4 W) time points

Time point (sample size)	2 W (n = 27)		4 W (n = 28)
	Frequency (% of 27)	Mean dose (Min–Max; SD)	Frequency (% of 28)	Mean dose (Min–Max; SD)
Methylphenidate	11 (41.7)	33.6 mg (5–72; 20.8)	12 (42.9)	44.3 mg (10–80; 22.2)
Amphetamine	–	–	1 (3.6)	10 mg (−)
Dexamphetamine	7 (25.9)	21.8 mg (8–40; 11.9)	5 (17.9)	36.0 mg (5–90; 33.8)
Lisdexamfetamine	6 (22.2)	65 mg (20–150; 44.6)	7 (25.0)	58.6 mg (20–130; 36.7)
Atomoxetine hydrochloride	1 (3.7)	40 mg (−)	1 (3.6)	40 mg (−)
Guanfacine	1 (3.7)	4 mg (−)	1 (3.6)	4 mg (−)
Other: moclobemide	1 (3.7)	600 mg (−)	1 (3.6)	600 mg (−)